Kiniksa Pharmaceuticals International, plc
KNSA
$56.51
-$2.03-3.47%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 59.11% | -22.98% | 3.38% | 108.83% | 196.07% |
| Total Depreciation and Amortization | 0.21% | 21.61% | 7.26% | 3.77% | -13.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.97% | -15.89% | 37.26% | -2.32% | 76.18% |
| Change in Net Operating Assets | -60.12% | 2,644.25% | 38.96% | -204.19% | -92.21% |
| Cash from Operations | -6.86% | 60.03% | 19.89% | 25.83% | 18.93% |
| Capital Expenditure | 74.57% | 5.66% | -306.67% | -66.67% | 48.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 54.75% | -13.04% | -1,569.82% | 92.77% | -178.55% |
| Cash from Investing | 54.93% | -12.84% | -1,516.15% | 92.47% | -178.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -25.50% | -47.23% | 27.52% | 300.79% | 16.91% |
| Repurchase of Common Stock | 65.58% | 78.91% | -112.65% | -396.84% | 28.72% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -20.70% | -35.64% | 11.23% | 286.49% | 29.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 362.97% | 46.09% | -149.22% | 231.97% | -130.68% |